Wei-Le Wang

839 total citations
11 papers, 237 citations indexed

About

Wei-Le Wang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Wei-Le Wang has authored 11 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Wei-Le Wang's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (3 papers). Wei-Le Wang is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (3 papers). Wei-Le Wang collaborates with scholars based in United States, Japan and Spain. Wei-Le Wang's co-authors include Mark Boldin, Steven Vonderfecht, Ching‐Cheng Chen, Bijender Kumar, Nelson Chau, Edouard M. Cantin, Chandran Ramakrishna, Nicholas J. Kramer, Konstantin D. Taganov and Jun‐ichiro Inoue and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Wei-Le Wang

10 papers receiving 236 citations

Peers

Wei-Le Wang
Comparison fields: 5 of 57
  • Molecular Biology 135
  • Cancer Research 99
  • Immunology 84
  • Neurology 43
  • Surgery 20
Replace Wilson Pak-Kin Lou with:
Wilson Pak-Kin Lou China
Ramesh Menon India
Marit B. de Wissel Netherlands
Christopher B. Mahony United Kingdom
Marc Wiedner Austria
Yafeng Lv China
Zhenwen Yan China
Eddy T. H. Goh Singapore
Briana L. Winer United States
V Sai Chaluvadi United States
Wilson Pak-Kin Lou China View profile →
Citations per field, relative to Wei-Le Wang
Wei-Le Wang · 1×
Citations per year, relative to Wei-Le Wang
Wei-Le Wang · 1×

Countries citing papers authored by Wei-Le Wang

Since Specialization
Citations

This map shows the geographic impact of Wei-Le Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Le Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Le Wang more than expected).

Fields of papers citing papers by Wei-Le Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Le Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Le Wang. The network helps show where Wei-Le Wang may publish in the future.

Co-authorship network of co-authors of Wei-Le Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Le Wang. A scholar is included among the top collaborators of Wei-Le Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Le Wang. Wei-Le Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 8
2 4
3 42
4 18
5 13
6 1
7 0
8 16
9 43
10 90
11 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026